UBS raised the firm’s price target on Iqvia to $300 from $240 and keeps a Buy rating on the shares. The company’s Q4 results and FY24 guidance support the thesis that Iqvia’s healthy backlog and tech/data-forward offering should enable market share gains, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IQV: